Holen Sie sich die Stockscreener-App
199.82
3.49%
7.24
Handel nachbörslich:
199.00
-0.82
-0.41%
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt DVA?
Forum
Prognose
Aktiensplit
Schlusskurs vom Vortag:
$192.58
Offen:
$193.67
24-Stunden-Volumen:
498.72K
Relative Volume:
0.57
Marktkapitalisierung:
$12.82B
Einnahmen:
$13.84B
Nettoeinkommen (Verlust:
$1.10B
KGV:
19.18
EPS:
10.4185
Netto-Cashflow:
$1.49B
1W Leistung:
+0.33%
1M Leistung:
+37.86%
6M Leistung:
+63.97%
1J Leistung:
+38.79%
1-Tages-Spanne:
$191.57
$199.90
1-Wochen-Bereich:
$191.57
$202.69
52-Wochen-Spanne:
$101.00
$202.69
Davita Inc Stock (DVA) Company Profile
Firmenname
Davita Inc
Sektor
Branche
Telefon
310-536-2668
Adresse
2000 16TH STREET, DENVER, CO
Compare DVA vs HCA, THC, FMS, EHC
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
DVA
Davita Inc
|
199.77 | 12.36B | 13.84B | 1.10B | 1.49B | 10.42 |
HCA
Hca Healthcare Inc
|
423.00 | 95.99B | 76.39B | 7.81B | 7.93B | 29.08 |
THC
Tenet Healthcare Corp
|
196.64 | 17.10B | 21.46B | 2.65B | 3.35B | 19.23 |
FMS
Fresenius Medical Care Ag Adr
|
21.59 | 11.53B | 22.18B | 1.36B | 2.00B | 1.9216 |
EHC
Encompass Health Corp
|
106.63 | 10.64B | 6.07B | 793.80M | 464.40M | 5.9914 |
Davita Inc Stock (DVA) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-03-06 | Eingeleitet | Barclays | Equal Weight |
| 2023-08-07 | Hochstufung | UBS | Neutral → Buy |
| 2022-11-01 | Herabstufung | Deutsche Bank | Buy → Hold |
| 2022-10-31 | Herabstufung | UBS | Buy → Neutral |
| 2022-08-19 | Fortgesetzt | UBS | Buy |
| 2022-06-21 | Bestätigt | BofA Securities | Underperform |
| 2021-09-10 | Eingeleitet | Cowen | Market Perform |
| 2021-08-12 | Herabstufung | Barclays | Overweight → Equal Weight |
| 2021-03-26 | Herabstufung | BofA Securities | Neutral → Underperform |
| 2021-01-05 | Herabstufung | BofA Securities | Buy → Neutral |
| 2020-01-24 | Hochstufung | Goldman | Neutral → Buy |
| 2019-11-07 | Herabstufung | Raymond James | Outperform → Mkt Perform |
| 2019-10-25 | Herabstufung | Wolfe Research | Outperform → Peer Perform |
| 2019-09-11 | Herabstufung | William Blair | Outperform → Mkt Perform |
| 2019-07-26 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2019-01-08 | Hochstufung | UBS | Sell → Neutral |
| 2019-01-03 | Eingeleitet | Deutsche Bank | Buy |
| 2018-12-14 | Eingeleitet | Barclays | Overweight |
| 2018-11-28 | Hochstufung | Raymond James | Mkt Perform → Outperform |
| 2018-11-16 | Eingeleitet | UBS | Sell |
| 2018-11-08 | Herabstufung | Raymond James | Strong Buy → Mkt Perform |
| 2018-09-13 | Hochstufung | JP Morgan | Underweight → Neutral |
| 2018-01-04 | Hochstufung | BofA/Merrill | Neutral → Buy |
| 2017-12-12 | Hochstufung | Robert W. Baird | Neutral → Outperform |
| 2017-12-11 | Hochstufung | Citigroup | Neutral → Buy |
| 2017-12-07 | Hochstufung | Raymond James | Outperform → Strong Buy |
| 2017-11-08 | Bestätigt | RBC Capital Mkts | Sector Perform |
| 2017-10-09 | Herabstufung | JP Morgan | Neutral → Underweight |
| 2017-06-26 | Herabstufung | Jefferies | Buy → Hold |
| 2016-12-13 | Herabstufung | Robert W. Baird | Outperform → Neutral |
Alle ansehen
Davita Inc Aktie (DVA) Neueste Nachrichten
DaVita Inc. stock (US23918K1088): strong year-to-date rally despite latest pullback in healthcare se - AD HOC NEWS
The 5 Most Interesting Analyst Questions From DaVita’s Q1 Earnings Call - Yahoo Finance
DaVita Inc. stock underperforms Thursday when compared to competitors - MarketWatch
Does DaVita Insider Equity Move Signal Governance in Russell 1000? - Kalkine Media
DaVita CFO & Treasurer Joel Ackerman Sells 34% Of Holding - simplywall.st
DaVita stock (US23918K1088): TD Cowen raises price target after Q1 earnings - AD HOC NEWS
Insider Sell Alert: David Maughan Sells 20,529 Shares of DaVita Inc (DVA) - GuruFocus
DaVita Inc. stock underperforms Wednesday when compared to competitors - MarketWatch
DaVita COO David Maughan sells $4.09 million in company stock By Investing.com - Investing.com South Africa
DaVita(DVA.US) Officer Sells US$4.09 Million in Common Stock - Moomoo
What Does DaVita Inc.'s (NYSE:DVA) Share Price Indicate? - Moomoo
DaVita stock (US23918K1088): Q1 EPS beat and raised full-year guidance - AD HOC NEWS
What Are Wall Street Analysts' Target Price for DaVita Stock? - Barchart.com
DaVita Stock Rockets 32% With 7-Day Winning Streak - Trefis
Here's Why DaVita HealthCare (DVA) is a Strong Momentum Stock - Yahoo Finance
DaVita stock (US23918K1088): TD Cowen raises price target to $201 - AD HOC NEWS
DaVita Stock 6-Day Winning Spree: Stock Climbs 31% - Trefis
Insider Sell: Joel Ackerman Sells 51,471 Shares of DaVita Inc (D - GuruFocus
DaVita (DVA) Leads Goldman Sachs' Buyback Aristocrats Index with Aggressive Share Repurchases - GuruFocus
DaVita Inc (DVA) Stock Price, Trades & News - GuruFocus
DaVita HealthCare (DVA) Is Up 30.99% in One Week: What You Should Know - Yahoo Finance
DaVita stock (US23918K1088): Q1 beat and raised guidance lift shares - AD HOC NEWS
DaVita Inc. (DVA) Stock Analysis: Evaluating Growth Potential Amidst a Robust Market Position - DirectorsTalk Interviews
DVA Stock Price, Quote & Chart | DAVITA INC (NYSE:DVA) - ChartMill
DaVita Inc. stock (US23918K1088): Q1 2026 beat lifts shares after guidance hike - AD HOC NEWS
DaVita Inc. stock (US23918K1088): Q1 2026 earnings and share buybacks lift sentiment - AD HOC NEWS
Evaluating DaVita (DVA) After A Strong Share Price Rally And Mixed Valuation Signals - Yahoo Finance
DaVita Stock 5-Day Winning Spree: Stock Climbs 31% - Trefis
Insider Sell: James Hearty Sells Shares of DaVita Inc (DVA) - GuruFocus
DaVita Inc. stock underperforms Friday when compared to competitors despite daily gains - MarketWatch
Surging Earnings Estimates Signal Upside for DaVita HealthCare (DVA) Stock - Yahoo Finance
DaVita Inc stock (US23804L1035): Shares surge after Q1 beat and guidance hike - AD HOC NEWS
Here's Why DaVita HealthCare (DVA) is a Strong Value Stock - Yahoo Finance
DaVita Inc. Stock (US23918K1088): Analyst Upgrade and Earnings Outlook Drive Investor Interest - AD HOC NEWS
DaVita (DVA) Sees 19.6% Surge, Reaches $187.75 - GuruFocus
DaVita (DVA) Revenue Growth Drives Deutsche Bank Upgrade to Buy Rating - Insider Monkey
DaVita Inc. stock outperforms competitors on strong trading day - MarketWatch
DaVita (DVA) Is Up 27.6% After Boosting 2026 EPS Guidance On Strong Q1 Results - Yahoo Finance
UBS Adjusts Price Target on DaVita to $235 From $190, Maintains Buy Rating - marketscreener.com
Should Value Investors Buy DaVita (DVA) Stock? - Yahoo Finance
DaVita: Improved Volumes And Tech In Focus (Rating Upgrade) (NYSE:DVA) - Seeking Alpha
Barclays Adjusts Price Target on DaVita to $194 From $158 - marketscreener.com
DaVita Inc. (NYSE:DVA) Q1 2026 Earnings Call Transcript - Insider Monkey
DaVita Inc. Lifts Guidance After Earnings Beat - TipRanks
AMD Soars on AI Boom, Uber Climbs, DaVita Surges - StartupHub.ai
BofA raises DaVita stock price target to $145 on Q1 beat - Investing.com UK
DaVita CFO and VP to join investor chat at BofA Health Care Conference on May 12, 2026 - Pluang
DaVita Inc. to Participate in the BofA Securities 2026 Health Care Conference - ChartMill
Research Alert: CFRA Maintains Buy Rating On Shares Of Davita Inc. - 富途牛牛
DaVita raises annual guidance on robust dialysis demand - marketscreener.com
DaVita (DVA) Stock Jumps As Earnings Smash Expectations - timothysykes.com
Finanzdaten der Davita Inc-Aktie (DVA)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.68%
0.63%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):